U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545200) titled 'Ultrasonographic Evaluation of Masseter Muscle Changes After Botulinum Toxin Injection in ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543562) titled 'Selenium Intervention Registry Randomized Trial in Heart Failure' on April 07. Brief Summ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545720) titled 'Pinoxin for the Prevention of Radiation-Induced Skin Injury' on April 15. Brief Summary: ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544992) titled 'Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T ... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07546110) titled 'An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy o... Read More
U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544537) titled 'A Prospective Comparative Study of Autologous Bone Marrow-Derived and Adipose Tissue-Deriv... Read More
नई दिल्ली, अप्रैल 23 -- सैमसंग गैलेक्सी वॉच के शौकीनों के लिए अप्रैल 2026 एक बेहतरीन समय है, क्योंकि अमेज़न इंडिया पर इसके लेटेस्ट मॉडल्स की कीमतों में भारी गिरावट आई है। इस सेल में मुख्य आकर्षण Samsu... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 23 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More